Priority Date: 28.12.11 (JP 20110287654)

HUMANIZED ANTI-EPIREGULIN ANTIBODY, AND CANCER THERAPEUTIC AGENT COMPRISING SAID ANTIBODY AS ACTIVE INGREDIENT

  • Application ID: EP12863154
  • Status: EXAMINATION IN PROGRESS

Attorney

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This patent has the IPC combination A61, C07, and C12 Vossius & Partner Patentanwälte Rechtsanwälte mbB is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB, Isenbruck Bösl Hörschler LLP and 126 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 28.12.2011 - Priority Date (JP 20110287654)
  • 04.07.2013 - Publication A1 (WO2013100120)
  • 05.11.2014 - Publication A1 (EP2799543)